A comprehensive investigation into the effect of bisphenol A on the expression of drug-metabolizing enzymes: Consequences for endogenous metabolites and xenobiotic pharmacokinetics
Drug Metabolism and Disposition · 2026-08 · 54 (8) · 100361
DOI: 10.1016/j.dmd.2026.100361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-08. Verfasst von Ananthu Malaplakkal Raju und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India. Hauptthemen laut MEDLINE: Benzhydryl Compounds, Phenols, Xenobiotics, Endocrine Disruptors. Die Arbeit nennt 61 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Bisphenol A, a known endocrine disruptor, is a pervasive environmental contaminant because of its widespread use in everyday consumer products. It has been linked to numerous health hazards and shown to modulate the drug-metabolizing enzymes. There is a significant disparity in reported results in the literature, chiefly because of a focus on mRNA expression or substrate activity assays rather than on protein expression. The present study uses mass spectrometry-based targeted proteomics to investigate modulation in the expression of drug-metabolizing enzymes following environmentally relevant exposure to bisphenol A in a rat model. Furthermore, the plasma levels of endogenous metabolites of cytochrome P450 (CYP) 1B1, the highest fold-modulated enzyme, were also monitored. The pharmacokinetics of diclofenac, a substrate of the CYP2C family and UDP-glucuronosyltransferase (UGT) 2B7, were also studied. We identified 9 significantly altered proteins in hepatic drug metabolism, with 4 upregulated (CYP1B1, CYP1A2, UGT2B7, and UGT1A3) and 5 downregulated (CYP2A3, CYP2C13, CYP4A2, and UGT2B1). The upregulation of CYP1B1 leads to increased levels of endogenous metabolites, including retinoic acid and 4-hydroxyestradiol, which are teratogenic and procarcinogenic, respectively. The upregulation of UGT2B7 led to increased exposure to the acyl-glucuronide metabolite of diclofenac, which is known to cause hepatotoxicity, intestinal ulceration, and nephrotoxicity. SIGNIFICANCE STATEMENT: This study uses a mass spectrometry-based targeted proteomics approach to monitor all relevant drug-metabolizing enzymes (DMEs) after exposure to bisphenol A in a rat model. The study presents protein-level data of relevant DMEs and identified 9 significantly altered DMEs in hepatic drug metabolism. The modulation of DMEs is reflected in alterations in numerous endogenous metabolite levels with plausible adverse consequences. Further, the pharmacokinetics of substrate xenobiotic modulated by these enzymes is also altered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India.
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, India. Electronic address: swapnil@niperguwahati.in.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Malaplakkal Raju, A., Shajkumar, K., Biswal, S. S., Suresh, A., Wankhade, S. M., Shaji, A. K., & Dengale, S. J. (2026). A comprehensive investigation into the effect of bisphenol A on the expression of drug-metabolizing enzymes: Consequences for endogenous metabolites and xenobiotic pharmacokinetics. Drug Metabolism and Disposition, 54(8), 100361. https://doi.org/10.1016/j.dmd.2026.100361
Vancouver
Malaplakkal Raju A, Shajkumar K, Biswal SS, Suresh A, Wankhade SM, Shaji AK, et al. A comprehensive investigation into the effect of bisphenol A on the expression of drug-metabolizing enzymes: Consequences for endogenous metabolites and xenobiotic pharmacokinetics. Drug Metabolism and Disposition. 2026;54(8):100361. doi:10.1016/j.dmd.2026.100361
BibTeX
@article{MalaplakkalRaju2026,
author = {Malaplakkal Raju, Ananthu and Shajkumar, Kannan and Biswal, Subhashree Subhasmita and Suresh, Aiswarya and Wankhade, Shrutika Milind and Shaji, Anandhu Kunnath and Dengale, Swapnil Jayant},
title = {A comprehensive investigation into the effect of bisphenol A on the expression of drug-metabolizing enzymes: Consequences for endogenous metabolites and xenobiotic pharmacokinetics},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {8},
pages = {100361},
doi = {10.1016/j.dmd.2026.100361}
}
EUVIMED